Private Trust Company’s Dr. Reddy's Laboratories RDY Stock Holding History

Private Trust Company’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,184	Closed	-$15.6K	–	2562
2025 Q1	$15.6K	Buy	+1,184	New	+$16.3K	﹤0.01%	1653
2024 Q1	–	Sell	-60	Closed	-$835	–	2338
2023 Q4	$835	Sell	60 -295	-83%	-$3.94K	﹤0.01%	2209
2023 Q3	$4.75K	Buy	+355	New	+$4.8K	﹤0.01%	1894
2023 Q2	–	Sell	-335	Closed	-$3.81K	–	2361
2023 Q1	$3.81K	Buy	+335	New	+$3.62K	﹤0.01%	1936
2014 Q2	–	Sell	-430	Closed	-$4K	–	1997
2014 Q1	$4K	Sell	430 -60	-12%	-$522	﹤0.01%	1264
2013 Q4	$4K	Hold	490	–	–	﹤0.01%	1249
2013 Q3	$4K	Hold	490	–	–	﹤0.01%	1209
2013 Q2	$4K	Buy	+490	New	+$3.58K	﹤0.01%	1143

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Private Trust Company's RDY Position: Q2 2025 in Review

Private Trust Company sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 1,184 shares — an estimated $15.6K sold.

Private Trust Company first reported a position in RDY in Q2 2013 and held it in 8 quarters. The position peaked at $15.6K in Q1 2025. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

Private Trust Company reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
Private Trust Company sold 1,184 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $15.6K.
Private Trust Company first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 8 quarters.
Private Trust Company's Dr. Reddy's Laboratories position peaked at $15.6K in Q1 2025.
243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Private Trust Company's 13F filing for Q2 2025, filed 29 Jul 2025.